Stocks
Editas Medicine (EDIT) CAPEX/Revenue US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| CAPEX/Revenue, % | 30.0% | 7.89% | 31.2% | 20.9% | 6.04% | 15.5% | |||
| Changes by years, y/y, % | +15pp | -22pp | +23pp | -10pp | -15pp | -16.5% | |||
Editas Medicine. CAPEX/Revenue, %
Editas Medicine. CAPEX/Revenue, changes, pp
Editas Medicine (EDIT) CAPEX/Revenue US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| CAPEX/Revenue, % | 4.48% | 2.18% | 164.8% | 681.1% | 4 789% | 15.5% | ||
| Changes by years, y/y, % | -1 457pp | -7pp | +146pp | +635pp | +4 784pp | |||
| Changes by quarters, q/q, % | -42pp | -2pp | +163pp | +516pp | +4 107pp | |||
